Shikonin Induces Glioma Necroptosis, Stemness Decline, and Impedes (Immuno)Proteasome Activity
Gliomas, the most prevalent primary intracranial tumors, exhibit notable features such as heightened malignancy, rapid recurrence, and elevated mortality rates. Presently, standard therapeutic approaches yield limited curative outcomes. Shikonin, an extract derived from traditional Chinese medicine,...
Saved in:
Main Authors: | Xianyun Qin, Lu Zhang, Jilan Liu, Yan Lu, Fuyao Zhou, Feng Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2024/1348269 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design and synthesis of amino-substituted N-arylpiperidinyl-based inhibitors of the (immuno)proteasome
by: Gobec Martina, et al.
Published: (2023-09-01) -
Amino Acid-Mediated Metabolism: A New Power to Influence Properties of Stem Cells
by: Jilan Liu, et al.
Published: (2019-01-01) -
Shikonin Attenuates Concanavalin A-Induced Acute Liver Injury in Mice via Inhibition of the JNK Pathway
by: Tong Liu, et al.
Published: (2016-01-01) -
The Function of Necroptosis and Its Treatment Target in IBD
by: Francis Atim Akanyibah, et al.
Published: (2024-01-01) -
Ubiquitin Proteasome System in Stress and Disease
by: Dmitry Karpov, et al.
Published: (2012-01-01)